Serum CA 125 and survival of mice inoculated with ovarian carcinoma and treated with antiestrogen, estrogen, or progestin

This publication has 27 references indexed in Scilit:

• A phase II study of tamoxifen in ovarian cancer
  European Journal of Cancer and Clinical Oncology, 1986
• The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes
  BJOG: An International Journal of Obstetrics and Gynaecology, 1985
• Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
  British Journal of Cancer, 1984
• Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen
  American Journal of Obstetrics and Gynecology, 1984
• Östrogen- und Progesteronrezeptoren in malignen Ovarialtumoren
  Geburtshilfe und Frauenheilkunde, 1983
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983
• ³H‐estradiol and ³H‐R5020 binding in cytosols of normal and neoplastic human ovarian tissue
  International Journal of Cancer, 1983
• Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell Types
  American Journal of Clinical Pathology, 1983
• Advanced ovarian carcinoma: Response to antiestrogen therapy
  Cancer, 1981
• Reactivity of a monoclonal antibody with human ovarian carcinoma.
  Journal of Clinical Investigation, 1981